Sagimet Biosciences Inc.
SGMT
$10.55
$1.2713.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 129.70% | -7.59% | -3.06% | -6.95% | -13.25% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 26.63% | -9.72% | 22.39% | 129.62% | 61.95% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.54% | 35.14% | -3.80% | -36.95% | -10.70% |
| Total Current Assets | 126.51% | -7.46% | -2.57% | -6.07% | -12.92% |
|
|
|||||
| Total Current Assets | 126.51% | -7.46% | -2.57% | -6.07% | -12.92% |
| Net Property, Plant & Equipment | 4,902.56% | -50.00% | -32.17% | -24.34% | 300.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 144.47% | -7.49% | -9.28% | -6.55% | -6.00% |
|
|
|||||
| Total Accounts Payable | -50.89% | 75.94% | -69.15% | 120.87% | -40.40% |
| Total Accrued Expenses | 42.11% | -20.26% | -22.87% | -7.60% | 34.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 115.38% | -50.00% | -32.17% | -24.34% | 289.74% |
| Total Finance Division Other Current Liabilities | 73.33% | -44.44% | 237.50% | 700.00% | -98.41% |
| Total Other Current Liabilities | 73.33% | -44.44% | 237.50% | 700.00% | -98.41% |
| Total Current Liabilities | 2.30% | 3.84% | -44.23% | 26.20% | 0.93% |
|
|
|||||
| Total Current Liabilities | 2.30% | 3.84% | -44.23% | 26.20% | 0.93% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 37.34% | 3.84% | -44.23% | 26.20% | 0.93% |
|
|
|||||
| Common Stock & APIC | 36.51% | 0.40% | 0.37% | 0.43% | 0.35% |
| Retained Earnings | -3.91% | -3.07% | -2.84% | -3.99% | -3.31% |
| Treasury Stock & Other | -1,062.50% | -93.33% | 2.56% | 53.95% | -37.19% |
| Total Common Equity | 150.01% | -8.01% | -6.60% | -8.38% | -6.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 150.01% | -8.01% | -6.60% | -8.38% | -6.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 150.01% | -8.01% | -6.60% | -8.38% | -6.35% |
|
|
|||||